Our results demonstrated that E6446 could significantly suppress SCD1 activity, inhibit hepatic lipogenesis and adipogenic differentiation and improve HFD-induced hepatic steatosis via the target liver-adipose axis in an ATF3 dependent manner. The gene discussed is ATF3; the disease is Hepatic steatosis.